TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Scandbio AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2022/04 (consolidated) |
| Turnover |
100,050
|
55,666
|
89,497 |
| Financial expenses |
4
|
20
|
160 |
| Earnings before taxes |
17,770
|
12,501
|
6,854 |
| EBITDA |
18,909
|
13,550
|
9,262 |
| Total assets |
54,105
|
56,066
|
52,561 |
| Current assets |
37,751
|
40,548
|
35,561 |
| Current liabilities |
26,461
|
18,073
|
16,387 |
| Equity capital |
26,461
|
36,914
|
34,855 |
| - share capital |
541
|
539
|
582 |
| Employees (average) |
103
|
106
|
130 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2022/04 (consolidated) |
| Solvency |
48.9%
|
65.8%
|
66.3% |
| Turnover per employee |
971
|
525
|
688 |
| Profit as a percentage of turnover |
17.8%
|
22.5%
|
7.7% |
| Return on assets (ROA) |
32.9%
|
22.3%
|
13.3% |
| Current ratio |
142.7%
|
224.4%
|
217.0% |
| Return on equity (ROE) |
67.2%
|
33.9%
|
19.7% |
| Change turnover |
44,222
|
-27,256
|
1,596 |
| Change turnover % | 79% | 2% | |
| Chg. No. of employees |
-3
|
-24
|
-9 |
| Chg. No. of employees % | -3% | -6% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2022/04 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.